peptide-based targeted vaccines (DNL/HLA-antibody) (Immunomedics/Alexis)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namepeptide-based targeted vaccines (DNL/HLA-antibody) (Immunomedics/Alexis)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsNeoplasmsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunomedics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlexis BioImmunomedics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasmsVirus Diseases

Other Information

ATC CodeN/A
Related LinksN/A